Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06402656

Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion

The aim of the study is to compare a customized facemask for the treatment of Class III malocclusion in the prepubertal growing patient (patients between the ages of 5 and 12 years) versus a standard commercial facemask. Specifically, preference, pain, difficulty in sleeping, time of use, and possible complications for the two types of facemasks will be analyzed.

This is a single-center, national, controlled, superiority, randomized, crossover, open-label study.

Each patient will be treated with both the customized facemask and the standard commercial facemask. Each patient will wear one type of facemask for 2 months and the other type of facemask for the next 2 months. After 2 weeks and at the end of therapy with each of the facemask types, the patient, with the possible help of the parents, will have to answer a questionnaire about pain and difficulty sleeping and report any complications. In addition, after completing both phases (fourth month), the patient should indicate a preference for one of the two types of mask with which to complete therapy for an additional 6 months.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

5 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 5 and 12 years;
  • Class III malocclusion, for which early orthopedic treatment with rapid maxillary expander and facemask is indicated.
  • signing of informed consent

Exclusion criteria

  • Cleft lip and/or palate.
  • Craniofacial syndromes.

Treatment and study plan

Customized facemask

Device

The customized face mask will be fabricated from a 3D digital image of the patient's face obtained by means of a 3D scanner. Such a scanner consists of 6 digital SLR cameras and software capable of processing a 3-D image of the patient's face exportable as an stl file.

Standard facemask

Device

The standard facemask is the commercially available Petit standard facemask

Primary outcomes

  1. Questionnaire on the preference of the patient for one of the two types of face masks

    Time frame: 4 months

    The primary endpoint is a questionnaire on the preference between the two types of face masks at the end of the second phase of therapy (4 months after delivery of the first face mask)

Secondary outcomes

  1. Pain reported by patients

    Time frame: At 2 weeks and at 2 months after delivery of each of the 2 face masks

    Pain measured through Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean worse pain.

  2. Difficulty in sleeping reported by patients

    Time frame: At 2 weeks and at 2 months after delivery of each of the 2 face masks

    Difficulty in sleeping measured through VAS Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean more difficulty in sleeping.

  3. Number of complications

    Time frame: At 2 weeks and at 2 months after delivery of each of the 2 face masks

    Number of complications

  4. Total time wear

    Time frame: At 2 months after delivery of each of the 2 face masks

    Total time wear measured with a thermosensor (Theramon)

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliero-Universitaria Careggi

Other

Registry information

Official study title

Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion: Randomized Crossover Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
May 7, 2024
Registry last updated
Jul 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.